The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment.

Bougherara H, Subra F, Crépin R, Tauc P, Auclair C, Poul MA

Open source

DOI
10.1158/1541-7786.mcr-09-0138
Published
2009 Sep
Container
Molecular cancer research : MCR
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1158/1541-7786.mcr-09-0138,
  title = {The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment.},
  author = {Bougherara H and Subra F and Crépin R and Tauc P and Auclair C and Poul MA},
  year = {2009},
  journal = {Molecular cancer research : MCR},
  doi = {10.1158/1541-7786.mcr-09-0138},
  url = {https://doi.org/10.1158/1541-7786.mcr-09-0138}
}

RIS

TY  - JOUR
TI  - The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment.
AU  - Bougherara H
AU  - Subra F
AU  - Crépin R
AU  - Tauc P
AU  - Auclair C
AU  - Poul MA
PY  - 2009
JO  - Molecular cancer research : MCR
DO  - 10.1158/1541-7786.mcr-09-0138
UR  - https://doi.org/10.1158/1541-7786.mcr-09-0138
ER  - 

APA

H, B., F, S., R, C., P, T., C, A., & MA, P. (2009). The aberrant localization of oncogenic kit tyrosine kinase receptor mutants is reversed on specific inhibitory treatment.. Molecular cancer research : MCR. https://doi.org/10.1158/1541-7786.mcr-09-0138

Source records